Thursday, 23 February 2012

Ryan Braun

Ryan Braun, the National League MVP winner of the 2011 season and outfielder for the Milwaukee Brewers, won his appeal against a suspension which was the outcome of testing positive for performance enhancing drugs (PEDs). This does not mean that Braun did not use PEDS, however, just that he will be available to play this season. The league is apparently very angry and wants to take this case to the federal court in order to have the decision overturned. 
Braun tested positive for elevated testosterone levels in the fall, but denies using steriods. The problem is that the testosterone is exogenous, meaning it came from outside the body. He had just been named MVP, which was surprising to many because Matt Kemp was more deserving as some argued. This puts a big back eye on the MLB and baseball, especially since the MVP winner took PEDs. Braun was happy of the outcome and hopes to clean his record and image. "It is the first step in restoring my good name and reputation. We were able to get through this because I am innocent and the truth is on our side."Had he been suspended, last year's NL Central division champs would've been in tough to win games with super slugger Prince Fielder playing in Detroit now.The reason this was overturned was because the man who picked up the urine sample from Braun was supposed to Fedex it as soon as possible. Instead of sending it out on saturday for fear that the depot was closed, he kept it in a cool place, and sent it out Monday. This was enough to change the ruling. Sources have said the MLB is mad about this and will fight it. Sports continue to constantly have drug problems, and every year in every major sport (except hockey), someone is being caught for abusing steroids. They need to crack down harder and test more. Or have separate leagues for steroid users. Imagine various sports with giant players all over the field. It's not safe or healthy, but would have fans. This marks the first time a drug-related suspension has been overturned.

No comments:

Post a Comment